Table 2—

Comparison of pulmonary function tests before and after nebulization of the radiolablled amikacin aerosol using the Wilcoxon test

Before nebulizationAfter nebulizationp-value
FEV1 %58.9 (43.2–74.7)57.9 (43.2–72.6)0.40
FVC %81.4 (66.3–96.6)81.2 (67.2–95.1)0.93
FEF25–75 %37.5 (21.8–53.3)34.2 (22.2–46.1)0.25
  • The data are presented as mean (95% confidence intervals of the mean)

  • FEV1: forced expiratory volume in one second

  • FVC: forced vital capacity

  • FEF25–75 %: forced mid-expiratory flow